FI950729A - Mitogeneesia ja motogeneesia inhiboivat peptidit - Google Patents

Mitogeneesia ja motogeneesia inhiboivat peptidit Download PDF

Info

Publication number
FI950729A
FI950729A FI950729A FI950729A FI950729A FI 950729 A FI950729 A FI 950729A FI 950729 A FI950729 A FI 950729A FI 950729 A FI950729 A FI 950729A FI 950729 A FI950729 A FI 950729A
Authority
FI
Finland
Prior art keywords
motogenesis
peptides
inhibit mitogenesis
mitogenesis
inhibit
Prior art date
Application number
FI950729A
Other languages
English (en)
Swedish (sv)
Other versions
FI950729A0 (fi
Inventor
Paolo Comoglio
Carola Ponzetto
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939313528A external-priority patent/GB9313528D0/en
Priority claimed from GB9407673A external-priority patent/GB9407673D0/en
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of FI950729A0 publication Critical patent/FI950729A0/fi
Publication of FI950729A publication Critical patent/FI950729A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI950729A 1993-06-30 1995-02-17 Mitogeneesia ja motogeneesia inhiboivat peptidit FI950729A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939313528A GB9313528D0 (en) 1993-06-30 1993-06-30 Peptide inhibitors of mitogenesis and motogenesis
GB9407673A GB9407673D0 (en) 1994-04-18 1994-04-18 Peptide inhibitors of mitogenesis and motogenius
PCT/EP1994/001943 WO1995001376A1 (en) 1993-06-30 1994-06-15 Peptide inhibitors of mitogenesis and motogenesis

Publications (2)

Publication Number Publication Date
FI950729A0 FI950729A0 (fi) 1995-02-17
FI950729A true FI950729A (fi) 1995-04-19

Family

ID=26303150

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950729A FI950729A (fi) 1993-06-30 1995-02-17 Mitogeneesia ja motogeneesia inhiboivat peptidit

Country Status (15)

Country Link
US (2) US5594105A (fi)
EP (1) EP0662090A1 (fi)
JP (1) JP3585044B2 (fi)
KR (1) KR950703003A (fi)
CN (1) CN1056153C (fi)
AU (1) AU670704B2 (fi)
CA (1) CA2142713A1 (fi)
FI (1) FI950729A (fi)
HU (1) HU219813B (fi)
IL (1) IL110160A (fi)
MY (1) MY130026A (fi)
NZ (1) NZ268006A (fi)
PL (1) PL179628B1 (fi)
RU (1) RU2146262C1 (fi)
WO (1) WO1995001376A1 (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024915A1 (en) * 1994-03-17 1995-09-21 National Jewish Center For Immunology And Respiratory Medicine Product and process for regulating signal transduction pathways
US5744313A (en) * 1994-12-09 1998-04-28 The Regents Of The University Of California Assay employing novel protein domain which binds tyrosine phosphorylated proteins
US5807989A (en) * 1994-12-23 1998-09-15 New York University Methods for treatment or diagnosis of diseases or disorders associated with an APB domain
US6107457A (en) * 1995-02-16 2000-08-22 Board Of Regents, The University Of Texas System Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth
US5646036A (en) * 1995-06-02 1997-07-08 Genentech, Inc. Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies
US6214344B1 (en) 1995-06-02 2001-04-10 Genetech, Inc. Hepatocyte growth factor receptor antagonists and uses thereof
US5686292A (en) * 1995-06-02 1997-11-11 Genentech, Inc. Hepatocyte growth factor receptor antagonist antibodies and uses thereof
GB9603227D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use
CN1319133A (zh) 1998-09-25 2001-10-24 儿童医疗中心有限公司 选择性地调节蛋白激酶活性的短肽
US7226991B1 (en) * 1999-03-23 2007-06-05 United States Of America, Represented By The Secretary, Department Of Health And Human Services Phenylalanine derivatives
EP1163262B1 (en) * 1999-03-23 2011-05-11 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Phenylalanine derivatives
IL131142A0 (en) * 1999-07-28 2001-01-28 Rad Ramot Prognosis of breast cancer and other diseases
EP1223959B1 (en) 1999-10-22 2007-05-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain
US7871981B2 (en) * 1999-10-22 2011-01-18 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell motility, angiogenesis, and metastasis
WO2001049709A1 (en) * 2000-01-03 2001-07-12 Ramot University Authority For Applied Research & Industrial Development Ltd. Glycogen synthase kinase-3 inhibitors
EP1383792A2 (en) * 2000-08-22 2004-01-28 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Sh2 domain binding inhibitors
US7425537B2 (en) * 2000-08-22 2008-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SH2 domain binding inhibitors
US7378432B2 (en) 2001-09-14 2008-05-27 Tel Aviv University Future Technology Development L.P. Glycogen synthase kinase-3 inhibitors
US20050004008A1 (en) * 2002-03-01 2005-01-06 Frackelton A. Raymond SHC proteins as therapeutic targets in proliferative diseases
AU2003228225B2 (en) * 2002-03-01 2010-05-13 Roger Williams Hospital SHC protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
EP1569956B1 (en) 2002-12-12 2014-02-26 Tel Aviv University Future Technology Development L.P. Glycogen synthase kinase-3 inhibitors
US20040138104A1 (en) * 2003-01-14 2004-07-15 The Government Of The United States Of America Represented By The Secretary, Peptides
US7189694B2 (en) * 2003-04-18 2007-03-13 University Of Florida Research Foundation, Inc. Inhibitors of autophosphorylation protein kinases
US20050119163A1 (en) * 2003-09-18 2005-06-02 The Government Of The United States Of America, As Represented By The Secretary, SH2 domain binding inhibitors
PL1773885T3 (pl) 2004-08-05 2010-09-30 Genentech Inc Humanizowani antagoniści anty c-met
SG161281A1 (en) 2005-04-15 2010-05-27 Genentech Inc Hgf beta chain variants
JP2009516167A (ja) * 2005-11-11 2009-04-16 ロジャー・ウィリアムズ・ホスピタル 癌処置における予測マーカーとしてのｐ６６−ｓｈｃ
US20090054366A1 (en) * 2007-06-15 2009-02-26 Reliance Life Sciences Pvt. Ltd. RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY
RU2486245C2 (ru) * 2007-10-15 2013-06-27 Чугаи Сейяку Кабусики Кайся Способ получения клетки, способной продуцировать гетеропротеины с высоким выходом
IT1397874B1 (it) * 2008-09-30 2013-02-04 Multimedica Holding S P A Uso di peptidi nella terapia antiangiogenica
IT1397873B1 (it) * 2008-09-30 2013-02-04 Multimedica Holding S P A Uso di peptidi nella terapia antiangiogenica relativa a patologie tumorali
AR086823A1 (es) 2011-06-30 2014-01-22 Genentech Inc Formulaciones de anticuerpo anti-c-met, metodos
MA39776A (fr) 2014-03-24 2017-02-01 Hoffmann La Roche Traitement du cancer avec des antagonistes de c-met et corrélation de ces derniers avec l'expression de hgf
CN105504016B (zh) * 2014-05-29 2019-01-01 生工生物工程（上海）股份有限公司 一种治疗癌症的肽变体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
EP0584125B1 (en) * 1991-05-10 1997-07-16 PHARMACIA & UPJOHN S.p.A. Truncated forms of the hepatocyte growth factor (hgf) receptor
DE4136443A1 (de) * 1991-11-06 1993-05-13 Boehringer Ingelheim Int Expression der reifen proteinase 2a, ihre partielle reinigung und bereitstellung kompetitiv wirkender substrate
US7642971B2 (en) * 2007-05-25 2010-01-05 Sony Ericsson Mobile Communications Ab Compact diversity antenna arrangement

Also Published As

Publication number Publication date
IL110160A0 (en) 1994-10-07
CA2142713A1 (en) 1995-01-12
HU219813B (hu) 2001-08-28
PL307742A1 (en) 1995-06-12
AU7071894A (en) 1995-01-24
CN1111455A (zh) 1995-11-08
CN1056153C (zh) 2000-09-06
RU95108385A (ru) 1997-03-20
WO1995001376A1 (en) 1995-01-12
JP3585044B2 (ja) 2004-11-04
NZ268006A (en) 1996-09-25
JPH08500845A (ja) 1996-01-30
EP0662090A1 (en) 1995-07-12
HU9500919D0 (en) 1995-05-29
KR950703003A (ko) 1995-08-23
PL179628B1 (pl) 2000-10-31
RU2146262C1 (ru) 2000-03-10
HUT71324A (en) 1995-11-28
AU670704B2 (en) 1996-07-25
US5912183A (en) 1999-06-15
MY130026A (en) 2007-05-31
IL110160A (en) 2000-06-29
US5594105A (en) 1997-01-14
FI950729A0 (fi) 1995-02-17

Similar Documents

Publication Publication Date Title
FI950729A (fi) Mitogeneesia ja motogeneesia inhiboivat peptidit
FI931229A (fi) Som glanspigment laempade blandningar
BR9307895A (pt) Cadeira
FI931069A0 (fi) Kolloidalt rostat kaffe som aromatiseringsprodukt
FI934751A0 (fi) Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner
FI933022A0 (fi) Radiosystem som bildar en traodloes lokalslinga
DE59401331D1 (de) Breitschlitzdüse
FI933507A0 (fi) Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav att anvaendas som kontrastmedel och foerfarande foer deras framstaellning
FI933099A (fi) Foerpackning, som laett kan oeppnas
ITGE940084A0 (it) Sedia
KR940020239U (ko) 발포기
DK57893D0 (da) Sprinkler
FI930528A0 (fi) Luftkuddskonstruktion som passagerarskydd i fordon
FI810U1 (fi) Staell som underlaettar mattvaett
FI934401A0 (fi) Lufttillfoerselsystem som hindrar milfoerbraenning
FI930018A0 (fi) Staell som underlaettar mattvaett
FI931598A0 (fi) Spelbraede foer som bokstavplattor formade spelbrickor
FI447U1 (fi) Foervaringsskrin som kan infaellas i en bordsskiva
FI945U1 (fi) Plagg som kan omvandlas
FI554U1 (fi) Reklam som aendrar faerg
FI922997A (fi) Tuggummi som innehaoller verksamma aemnen
FI934219A0 (fi) Foerbandsbalkkonstruktion som huvudsaklig baerare foer mellanbjaelklag i flervaeningshus (tt-foerbandsbalk)
FIU920599U0 (fi) Spanjolett som staeng, automatiskt
FI934005A0 (fi) Foerfarande foer visning av parkeringstid i en betalanordning foer parkering och en betalanordning foer parkering som visar parkeringstid
KR940021827U (ko) 안락의자

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.